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Summary
Objective: Osteonecrosis (ON) of the femoral head frequently leads to progressive collapse of the femoral head followed by degenerative
arthritis of the hip joint. Oxidative stress, which has been implicated in many pathological conditions, including vascular injury, recently has
been suggested to play a part in the development of ON. Catalase (CAT ) is a major antioxidant enzyme and a number of polymorphisms
in the CAT have been described as being associated with several diseases, such as hypertension, diabetes mellitus, Alzheimer’s disease,
and vitiligo. The aim of this study was to evaluate the association of CAT gene polymorphisms with ON of the femoral head (ONFH) in a
caseecontrol study.
Methods: Eight polymorphic sites of CAT were selected from public databases, and genotyped in 443 ONFH patients and 273 control subjects
using the Affymetrix Targeted Genotyping (TG) 3K chip array. The association analysis of genotyped single nucleotide polymorphisms (SNPs)
and haplotypes was performed with ONFH.
Results: The 89A> T, 20T>C, þ3033C> T, þ14539A> T, þ22348C> T, and þ24413T>C polymorphisms of the CAT gene were sig-
niﬁcantly associated with the risk of ONFH in all alternative analysis models (P range; 0.0001e0.035, odds ratio [OR]: 0.52e3.47). Particularly,
the minor allele of 89A> T, 20T>C and þ3033C> T had a protective effect on ONFH with signiﬁcance (P range: 0.0014e0.035, OR:
0.52e0.73). Further analysis based on pathological etiology showed that the genotypes of 89A> T, 20T>C, þ3033C> T,
þ14539A> T, and þ22348C> T, and þ24413T>C were also associated with the risk of ONFH in each subgroup with signiﬁcant P values.
Conclusions: These ﬁndings indicate that the polymorphisms of CAT are associated with the ONFH, and suggest that oxidative stress may
play an important role in the pathogenesis of ONFH.
ª 2008 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Osteonecrosis (ON) is the death of the cellular portion of the
bone, with subsequent structural changes, leading to pro-
gressive collapse of the femoral head followed by degener-
ative arthritis of the hip joint1. As the disease mainly occurs
in middle-aged men, it incurs substantial socioeconomic
costs, as well as a burden for patients and their families1,2.
Although the precise pathophysiology of ON of the femoral
head (ONFH) has not been completely elucidated, several
1061Osteoarthritis and Cartilage Vol. 16, No. 9possible causes of ONFH have been suggested, such as
thrombophilia and hypoﬁbrinolysis3, microvessel destruc-
tion4, fat embolism due to altered lipid metabolism, and in-
creased bone marrow pressure with fat cell enlargement5,6.
Recently, in vivo oxidative stress, which has been implicated
in numerous pathological condition7,8, including vascular
injury9, has been reported to play a role in the pathogenesis
of ON10,11. Kabata et al.12 have already reported on the role
of apoptosis in steroid-induced ON and characterized bone
hematopoietic cell apoptosis as the stage preceding ON.
Furthermore, some in vitro and animal studies have
suggested that oxidative stress decreases bone formation
by modulating the differentiation and survival of
osteoblasts13.
Oxidative stress is caused by an imbalance between
the production of reactive oxygen species (ROS) and
a biological system’s ability to readily detoxify the reac-
tive intermediates or easily repair the resulting damage14.
When additional oxidative events occur, the pro-oxidant
systems outbalance the antioxidant, potentially producing
oxidative damage to lipids, proteins, carbohydrates, and
nucleic acids, ultimately leading to cell death in severe
oxidative stress. For these reasons, this study’s attention
was drawn to oxidative stress, which is one of the fac-
tors inducing vascular injury and apoptosis, which are
thought to play a role in the development of steroid-in-
duced ON.
Catalase (CAT ) is an endogenous antioxidant enzyme
that protects cells against ROS damage by converting hy-
drogen peroxide to water and oxygen, thereby preventing
cellular injury15. Individuals with reduced CAT activity have
an increased incidence of oxidative stress related diseases,
such as atherosclerosis16, diabetes17,18, dyslipidaemia18
and neurodegenerative disease19. In addition, CAT administra-
tion was shown to prevent ovariectomy-induced bone loss20.
Recently, the association of the CAT gene polymorphisms
with hypertension21, diabetes22, Alzheimer’s disease23 and
vitiligo24 has been investigated. However, to our knowledge,
its genetic effects on ON have not been studied yet, despite
the presumptively important role of CAT in bone metabolism
and vascular integrity and function. Therefore, for the ﬁrst
time, this study has investigated the genetic effect of CAT
on the risk of ONFH.Materials and methodsSUBJECTSA total of 443 (366 men, 77 women; age: 49.7 13.3) unrelated patients
with ONFH and 273 (206 men, 67 women; age: 52.1 10.6) unrelated control
subjects were consecutively enrolled at the Kyungpook National University
Hospital (Daegu, Korea) from 2002 to 2006. Patients were diagnosed and
subgrouped by criteria which were described previously25. According to
etiological factors, patients were subgrouped into one of the following groups:
idiopathic (181 cases), steroid-induced (56 cases), and alcohol-induced
(206 cases) ON groups. The control subjects were deﬁned by if they had
no hip pain and if anteroposterior and frog leg lateral pelvic radiographs did
not show any lesions with a sclerotic margin or subchondral collapse consis-
tent with ONFH. All individuals provided informed consent for their participa-
tion in the study and this project was approved by the Institutional Review
Board.GENOTYPINGThe genotyping was performed using the Affymetrix Targeted Genotyping
(TG) 3K chip array. A TG chip using molecular inversion probe (MIP) technol-
ogy with Gene chip universal microarrays provides a method that is capable
of analyzing thousands of variants in a single reaction. The basic concept of
MIP technology has been described previously26. The genotyping reactions
were carried out using the standard protocols recommended by the manufac-
turer (Affymetrix). The arrays were scanned with the GeneChip Scanner 30007G, and the images were analyzed using GCOS software (Affymetrix).
Finally, the TG analysis software measures the data quality and generates
genotypes for arrays which have met a speciﬁc set of quality control criteria.STATISTICSSigniﬁcant deviation of genotype frequency from the HardyeWeinberg
equilibrium (HWE) at each single nucleotide polymorphism (SNP) was
tested by c2 analysis. Logistical regression analyses were used to calcu-
late the odds ratios (ORs), 95% conﬁdence intervals (CIs) and corre-
sponding P values of each SNP and haplotypes controlling for age and
sex as covariates with three alternative models (codominant, dominant
and recessive). Haplotypes of the CAT gene were analyzed using Haplo-
view version 3.32 (http://www.broad.mit.edu/mpg/haploview/) based on ex-
pectation maximization (EM) algorithm27. The linkage disequilibrium (LD)
between loci was measured using the absolute value of Lewontin’s D0
ðjD0jÞ28. For multiple comparisons, a Bonferroni adjustment was used to
adjust P values. The statistical power of the sample was 0.8 if the differ-
ence of minor allele frequency (MAF) was over 0.1 between two groups.
All analyses were two-tailed and a P value< 0.05 was considered statis-
tically signiﬁcant. Statistics were performed using SAS 9.1 (SAS Institute
Inc., Cary, NC, USA).Results
In order to investigate the association of CAT gene poly-
morphism with ONFH, eight polymorphic sites of CAT were
selected by considering their position, allele frequencies
and relatedness with diseases from public databases, one
(89A> T) in the promoter region, one (20T>C) in the
50-UTR, ﬁve (þ3033C> T, þ5502T>A, þ7288T> A,
þ14539A> T, and þ24413T>C) in the intron, and one
(þ22348C> T) in the exon 9. The genotypes of eight
SNPs were analyzed in 443 ONFH patients and 273 control
subjects using the Affymetrix TG 3K chip array.
The genotype distribution of all studied polymorphisms
followed the HWE in this study’s sample set (Table I). The
P values of each polymorphism were analyzed with
respect to a comparison between ONFH patients and the
controls by logistic analysis. It was found that the
89A> T, 20T>C, þ3033C> T, þ14539A> T,
þ22348C> T, and þ24413T>C polymorphisms of the
CAT gene were signiﬁcantly associated with the risk of
ONFH in all alternative analysis models (P range:
0.0001e0.035, OR: 0.52e3.47). Particularly, possessing
two copies of the minor allele (genotype TT in þ14539
and þ22348, CC in þ24413, respectively, i.e., a recessive
model) was a particular risk factor, with an individual OR
ranging between 2.28 and 3.47 (Table II). However, the
minor allele of 89A> T, 20T>C and þ3033C> T had
a protective effect on ONFH with signiﬁcant P values (P
range: 0.0014e0.035, OR: 0.52e0.73). Further analysis
based on pathological etiology (alcohol-, steroid- or
idiopathic) showed that the genotypes of 89A> T,
20T>C, þ3033C> T, þ14539A> T, þ22348C> T, and
þ24413T>C were also associated with the risk of ONFH
in each subgroup with signiﬁcant P values (Table III).
Because LD has been suggested to be highly structured
as conserved blocks of sequence separated by hotspots
of recombination, the ﬁnal function of a conserved haplo-
type may be the result of interaction among polymor-
phisms within the block. The LD coefﬁcient between
polymorphisms was calculated which showed that all gen-
otyped polymorphisms are in strong LD (Table IV). Five
tagging SNPs in the LD block were selected, and haplo-
types were reconstructed and the haplotype frequencies
were compared between the controls and ONFH patients.
Haplotype analysis showed that haplotype ht2 (A-T-T-T-C)
was signiﬁcantly associated with the susceptibility to
ONFH in all alternative analysis models (P range:
Table I
Frequencies of CAT gene polymorphisms in ONFH patients and normal controls
Loci* Location NCBI rs# Amino acid change Genotype N Frequency Heterozygosity HWEy
89A> T Promoter rs7943316 AA AT TT 
277 325 88 
690 0.363 (T) 0.462 0.795
20T>C Exon 1 (50-UTR) rs1049982 TT CT CC 
300 314 98 
712 0.358 (C) 0.460 0.201
þ3033C> T Intron 1 rs525938 CC CT TT 
296 316 97 
709 0.360 (T) 0.461 0.308
þ5502A> T Intron 1 rs2268064 TT AT AA 
584 124 7 
715 0.097 (A) 0.175 0.308
þ7288A> T Intron 1 rs2300182 TT AT AA 
520 179 17 
716 0.149 (A) 0.254 0.599
þ14539A> T Intron 5 rs3758730 AA AT TT 
413 249 52 
714 0.247 (T) 0.372 0.440
þ22348C> T (C111T) Exon 9 rs769217 D389D CC CT TT 
275 315 125 
715 0.395 (T) 0.478 0.890
þ24413T>C Intron 9 rs2284365 TT CT CC 
274 314 127 
715 0.397 (C) 0.479 1.000
*Calculated from translational start site.
yP values of deviation from HWE in normal controls.
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lotype, ht3 (T-T-T-A-T) was signiﬁcantly lower in patients,
suggesting that haplotype ht3 had a protective effect on the
ONFH development (Table V, P range: 0.0077e0.0171,
OR: 0.68e0.71). But, haplotype association analysis did
not provide a higher OR or a more signiﬁcant result than
the OR and P values of single locus SNPs.
These results suggest that the CAT gene polymor-
phisms, a major antioxidant enzyme, might be associated
with an increased susceptibility of ONFH in the Korean
population. In addition, these polymorphisms may contrib-
ute to future studies regarding CAT functions and ON
development.Discussion
Non-traumatic ONFH has been associated with cortico-
steroid usage, alcoholism, infections, marrow inﬁltrating
diseases, coagulation defects, and some autoimmune dis-
eases. These risk factors are closely related with direct or
indirect injuries to the vascular supply to the bone1,29,30.
By reduction or disruption of the blood supply to the bone,
the bone marrow dies, eventually causing the bone to
collapse29,30.
Recently, in vivo oxidative stress has been reported to
play a role in the pathogenesis of ON10,11. Alcohol abuse
and steroid administration increase the fat volume in
bone marrow, which causes intraosseous hypertension
and occlusion of blood ﬂow to the femoral head. In addi-
tion, alcohol promotes the generation of ROS resulting in
oxidative stress. Steroid-induced ON in the rabbit demon-
strated that administration of steroids promotes to the de-
velopment of oxidative stress and oxidative injury in bone
tissue soon thereafter31. Under conditions of oxidative
stress, vascular and tissue injuries occur as a consequence
of decreasing levels of reduced glutathione (GSH), which
is necessary to maintain homeostasis, increased lipid per-
oxide, and protein modiﬁcations. It has been reported that
the administration of buthionine sulphoximine (BSO), whichis an inducer of oxidative stress, in animal model impairs
redox function by blocking the synthesis of GSH in the or-
ganism, thereby inducing ON11. This result suggests that
oxidative stress induced by decreased GSH is sufﬁcient
to cause ON. Tissue oxidation is also known to induce
apoptosis resulting in ON12.
The data presented here provide strong evidence of an
association between CAT gene variants and ONFH. Three
of the polymorphisms were found to be protective, and
three were found to increase risk (Table II). These associ-
ations held up for alcohol and idiopathic ONFH subgroups,
and three of the SNPs increased risk in the steroid-
induced ONFH subgroup (Table III). Even though the
Bonferroni correction was stringently adjusted for multiple
testing, most of the P values of associated SNPs and hap-
lotypes retained still signiﬁcance. These data support the
hypothesis that ONFH is caused in part by oxidative
stress.
A number of CAT gene SNPs and mutations have been
associated with disease manifestations such as catalase-
mia/hypocatalasemia, hypertension, and type 2 diabetes
mellitus17,21. Some reports have suggested that the
þ22348C> T (D389D) in exon 9 is a susceptible locus
for hypocatalasemia in Hungarians32and vitiligo in Cauca-
sians24. Allelic variants in the CAT gene which have del-
eterious effects upon the expression or function of CAT
could play a part in the low levels of enzyme activity33.
Therefore, this study has suggested that the decreased
expression or function of CAT in the osteonecrotic bone
area could affect apoptosis, vascular integrity, angiogene-
sis, repair processes and progression, and outcome of
ONFH. It was previously reported that polymorphisms in
the VEGF gene and the HIF1a hypoxia gene25 are also
associated with ONFH, suggesting that the etiology of
ONFH is quite complex. Hypoxia can induce both apopto-
sis as well as necrosis of cells and is associated with
vascular disease. HIF1 directly regulates the expression
of several genes involved in angiogenesis, such as
VEGF, FLT1 (VEGF receptor) and PAI-134. Under hyp-
oxia, the level of ROS generated by nicotinamide adenine
Table II
Analyses of association of CAT gene polymorphisms with the risk of ONFH
Loci Position Genotype Frequency Codominant Dominant Recessive
Cases Controls OR (95% CI) P P corr* OR (95% CI) P P corr* OR (95% CI) P P corr*
89A> T Promoter AA 185 (42.82) 92 (35.66) 0.73 (0.58e0.91) 0.0065 0.0520 0.73 (0.53e1.01) 0.0541 0.4328 0.54 (0.34e0.85) 0.0078 0.0624
AT 203 (46.99) 122 (47.29)
TT 44 (10.19) 44 (17.05)
20T>C 50-UTR TT 199 (45.23) 101 (37.13) 0.72 (0.58e0.90) 0.0034 0.0272 0.72 (0.52e0.98) 0.0352 0.2816 0.53 (0.35e0.82) 0.0043 0.0344
CT 193 (43.86) 121 (44.49)
CC 48 (10.91) 50 (18.38)
þ3033C> T Intron 1 CC 198 (45.31) 98 (36.03) 0.70 (0.56e0.88) 0.0018 0.0144 0.69 (0.50e0.94) 0.0197 0.1576 0.52 (0.34e0.81) 0.0034 0.0272
CT 192 (43.94) 124 (45.59)
TT 47 (10.76) 50 (18.38)
þ5502T>A Intron 1 TT 361 (81.67) 223 (81.68) 0.96 (0.67e1.38) 0.8080 1 1.01 (0.68e1.49) 0.9737 1 0.42 (0.09e1.89) 0.2569 1
AT 78 (17.65) 46 (16.85)
AA 3 (0.68) 4 (1.47)
þ7288T>A Intron 1 TT 315 (71.11) 205 (75.09) 1.20 (0.88,1.62) 0.2526 1 1.24 (0.88e1.76) 0.2206 1 1.12 (0.41e3.09) 0.8256 1
AT 117 (26.41) 62 (22.71)
AA 11 (2.48) 6 (2.2)
þ14539A> T Intron 5 AA 240 (54.3) 173 (63.6) 1.53 (1.18e1.97) 0.0012 0.0096 1.47 (1.08e2.01) 0.0159 0.1272 3.47 (1.60e7.53) 0.0016 0.0128
AT 158 (35.75) 91 (33.46)
TT 44 (9.95) 8 (2.94)
þ22348C> T (C111T) Exon 9 CC 154 (34.76) 121 (44.49) 1.51 (1.21e1.88) 0.0002 0.0016 1.50 (1.10e2.05) 0.0111 0.0888 2.32 (1.48e3.64) 0.0002 0.0016
CT 193 (43.57) 122 (44.85)
TT 96 (21.67) 29 (10.66)
þ24413T>C Intron 9 TT 153 (34.62) 121 (44.32) 1.50 (1.21e1.87) 0.0003 0.0024 1.50 (1.09e2.04) 0.0116 0.0928 2.28 (1.46e3.56) 0.0003 0.0024
CT 192 (43.44) 122 (44.69)
CC 97 (21.95) 30 (10.99)
Genotype distributions are shown as number (%). Logistic regression models were used for calculating ORs, 95% CIs, and corresponding P values for each SNP site. Age (continuous value)
and sex (male¼ 0, female¼ 1) were adjusted by inclusion in logistic analysis as covariates.
*P values after Bonferroni corrections. bold: P value< 0.05.
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Table III
Associations of CAT gene polymorphisms between the ONFH subgroup patients and controls
Loci Genotype Normal
controls
MAF Alcohol MAF P* Idiopathy MAF P* Steroid MAF P*
OR (95% CI) OR (95% CI) OR (95% CI)
89A> T AA 92 (35.66) 0.407 87 (43.07) 0.342 0.0606 76 (43.43) 0.32 0.0063z 22 (40) 0.373 0.3032
AT 122 (47.29) 92 (45.54) 0.77 (0.58e1.01) 86 (49.14) 0.66 (0.49e0.89) 25 (45.45) 0.79 (0.50e1.24)
TT 44 (17.05) 23 (11.39) 13 (7.43) 8 (14.55)
20T>C TT 101 (37.13) 0.406 93 (45.15) 0.335 0.0389z 83 (46.37) 0.31 0.0041 23 (41.82) 0.364 0.3248
CT 121 (44.49) 88 (42.72) 0.75 (0.57e0.99) 81 (45.25) 0.66 (0.50e0.88) 24 (43.64) 0.80 (0.52e1.24)
CC 50 (18.38) 25 (12.14) 15 (8.38) 8 (14.55)
þ3033C> T CC 98 (36.03) 0.412 91 (45.05) 0.332 0.0445z 83 (46.37) 0.313 0.0032 24 (42.86) 0.357 0.2274
CT 124 (45.59) 88 (43.56) 0.75 (0.57e0.99) 80 (44.69) 0.65 (0.49e0.87) 24 (42.86) 0.76 (0.49e1.19)
TT 50 (18.38) 23 (11.39) 16 (8.94) 8 (14.29)
þ5502T>A TT 223 (81.68) 0.099 163 (79.51) 0.105 0.9295 152 (83.98) 0.083 0.5697 46 (82.14) 0.098 0.6675
AT 46 (16.85) 41 (20) 0.98 (0.63e1.5) 28 (15.47) 0.87 (0.55e1.39) 9 (16.07) 1.16 (0.58e2.33)
AA 4 (1.47) 1 (0.49) 1 (0.55) 1 (1.79)
þ7288T>A TT 205 (75.09) 0.136 151 (73.3) 0.143 0.8302 123 (67.96) 0.174 0.1282 41 (73.21) 0.152 0.8759
AT 62 (22.71) 51 (24.76) 1.04 (0.71e1.53) 53 (29.28) 1.33 (0.92e1.92) 13 (23.21) 1.05 (0.58e1.90)
AA 6 (2.2) 4 (1.94) 5 (2.76) 2 (3.57)
þ14539A> T AA 173 (63.6) 0.197 110 (53.66) 0.285 0.0017 99 (54.7) 0.271 0.0099z 31 (55.36) 0.277 0.0088y,z
AT 91 (33.46) 73 (35.61) 1.67 (1.21e2.30) 66 (36.46) 1.52 (1.11e2.09) 19 (33.93) 4.82 (1.49e15.7)
TT 8 (2.94) 22 (10.73) 16 (8.84) 6 (10.71)
þ22348C> T
(C111T)
CC 121 (44.49) 0.331 73 (35.44) 0.43 0.0031 58 (32.04) 0.442 0.0010 23 (41.07) 0.429 0.0026y
CT 122 (44.85) 89 (43.2) 1.51 (1.15e1.99) 86 (47.51) 1.60 (1.21e2.11) 18 (32.14) 3.23 (1.51e6.92)
TT 29 (10.66) 44 (21.36) 37 (20.44) 15 (26.79)
þ24413T>C TT 121 (44.32) 0.333 73 (35.61) 0.429 0.0036 57 (31.49) 0.448 0.0008 23 (41.07) 0.429 0.0029y
CT 122 (44.69) 88 (42.93) 1.50 (1.14e1.97) 86 (47.51) 1.61 (1.22e2.12) 18 (32.14) 3.16 (1.48e6.76)
CC 30 (10.99) 44 (21.46) 38 (20.99) 15 (26.79)
*Codominant P values and OR (95% CI) for logistic analyses controlling for age and sex as covariates are shown.
yP values of recessive analysis model (homozygote for major alleleþ heterozygote vs homozygote for minor allele).
zP values were not signiﬁcant after Bonferroni corrections. bold: P value< 0.05.
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Table IV
Pairwise LD estimates among eight SNPs in CAT gene
SNPs jD0j
1 2 3 4 5 6 7 8
r2 89A> T (1) e 0.977 0.977 1 0.954 0.98 0.962 0.957
20T>C (2) 0.95 e 0.985 1 0.956 1 0.99 0.974
þ3033C> T (3) 0.947 0.968 e 1 0.978 0.981 0.984 0.979
þ5502T>A (4) 0.201 0.202 0.202 e 1 1 1 1
þ7288T>A (5) 0.082 0.081 0.085 0.018 e 1 0.992 0.992
þ14539A> T (6) 0.172 0.179 0.172 0.036 0.058 e 1 1
þ22348C> T (7) 0.322 0.339 0.336 0.07 0.251 0.517 e 1
þ24413T>C (8) 0.324 0.334 0.339 0.071 0.248 0.508 0.984 e
Table V
Association of CAT gene haplotypes with ONFH patients and normal controls
Loci Genotype Controls Patients Codominant Dominant Recessive
OR
(95% CI)*
P * P corry OR
(95% CI)*
P * P corr OR
(95% CI)*
P * P corr
ht1
(A-T-T-A-T)
/ 134 (52.14) 244 (56.74) 0.84
(0.65e1.09)
0.1853 NS 0.85
(0.62e1.16)
0.3007 NS 0.65
(0.33e1.29)
0.2197 NS
ht1/ 106 (41.25) 167 (38.84)
ht1/ht1 17 (6.61) 19 (4.42)
ht2
(A-T-T-T-C)
/ 165 (64.20) 236 (54.88) 1.52
(1.17e1.99)
0.0018 0.009 1.47
(1.07e2.03)
0.0182 NS 3.46
(1.52e7.88)
0.0032 0.016
ht2/ 85 (33.07) 155 (36.65)
ht2ht2 7 (2.72) 39 (9.07)
ht3
(T-T-T-A-T)
/ 126 (49.03) 250 (58.14) 0.71
(0.55e0.91)
0.0077 0.0385 0.68
(0.50e0.93)
0.0171 NS 0.56
(0.31e1.04)
0.064 0.321
ht3/ 109 (42.41) 157 (36.54)
ht3/ht3 22 (8.56) 23 (5.35)
ht4
(A-T-A-A-C)
/ 197 (76.65) 308 (71.63) 1.27
(0.92e1.74)
0.1457 NS 1.31
(0.92e1.88)
0.1386 NS 1.32
(0.45e3.87)
0.6102 NS
ht4/ 55 (21.40) 111 (25.81)
ht4/ht4 5 (1.95) 11 (2.56)
ht5
(T-A-T-A-T)
/ 210 (81.71) 351 (81.63) 0.96
(0.66e1.39)
0.8232 NS 1.03
(0.69e1.54)
0.8840 NS 0.27
(0.05e1.48)
0.1303 NS
ht5/ 43 (16.73) 77 (17.91)
ht5/ht5 4 (1.56) 2 (0.47)
Haplotypes: 89A> T/þ5502A> T/þ7288A> T/þ14539A> T/þ24413G>A.
*P values ORs (95% CI) of three alternative models (codominant, dominant, and recessive) by logistic regression analyses controlling for
age and sex as covariates.
yP values after Bonferroni corrections. NS; not signiﬁcant. bold: P value< 0.05.
1065Osteoarthritis and Cartilage Vol. 16, No. 9dinucleotide phosphate (NADPH) oxidase is attenuated
because of low pO2, which leads to stabilization of
HIF1a. Therefore, CAT gene might be directly or indirectly
related with the previously reported gene. This study sup-
posed that many other genes could also be involved in
ONFH development because the etiology of ONFH is
quite complex.
In summary, these results suggest that polymorphisms of
the CAT gene are likely to be associated with a susceptibility
to ONFH. To our knowledge, this study is the ﬁrst report that
shows the CAT polymorphisms and haplotypes are associ-
ated with ONFH. Further genetic and functional evidence
would be needed to conﬁrm the suggestive correlations
between the CAT polymorphism and ONFH.
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